Literature DB >> 3299401

The metabolism of triazene antitumor drugs.

A Gescher, M D Threadgill.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3299401     DOI： 10.1016/0163-7258(87)90059-3

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN： 0163-7258            Impact factor:   12.310


× No keyword cloud information.
  3 in total

1.  Structure/activity investigations in eight arylalkyltriazenes comparison of chemical stability, mode of decomposition, and SCE induction in Chinese hamster V79-E cells.

Authors:  R Thust; M Schneider; U Wagner; D Schreiber
Journal:  Cell Biol Toxicol       Date:  1991-04       Impact factor: 6.691

2.  O6-methylguanine-DNA methyltransferase activity and induction of novel immunogenicity in murine tumor cells treated with methylating agents.

Authors:  R Bianchi; L Citti; R Beghetti; L Romani; M D'Incalci; P Puccetti; M C Fioretti
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Comparison of the cytotoxicity in vitro of temozolomide and dacarbazine, prodrugs of 3-methyl-(triazen-1-yl)imidazole-4-carboxamide.

Authors:  L L Tsang; C P Quarterman; A Gescher; J A Slack
Journal:  Cancer Chemother Pharmacol       Date:  1991       Impact factor: 3.333
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.